| Active ingredient consistency of commercially available glucosamine sulfate products. AS Russell, A Aghazadeh-Habashi, F Jamali The Journal of rheumatology 29 (11), 2407-2409, 2002 | 150 | 2002 |
| Single dose pharmacokinetics and bioavailability of glucosamine in the rat A Aghazadeh-Habashi, S Sattari, F Pasutto, F Jamali J Pharm Pharm Sci 5 (2), 181-184, 2002 | 113 | 2002 |
| Simultaneous determination of amoxycillin and clavulanic acid in pharmaceutical dosage forms by LC with amperometric detection GK A Aghazadeh Journal of pharmaceutical and biomedical analysis 25 (2), 325-329, 2001 | 80 | 2001 |
| The glucosamine controversy; a pharmacokinetic issue A Aghazadeh-Habashi, F Jamali Journal of pharmacy & pharmaceutical sciences 14 (2), 264-273, 2011 | 77 | 2011 |
| High performance liquid chromatographic determination of glucosamine in rat plasma A Aghazadeh-Habashi, S Sattari, F Pasutto, F Jamali J Pharm Pharm Sci 5 (2), 176-180, 2002 | 66 | 2002 |
| Identification and quantitation of sodium-thyroxine and its degradation products by LC using electrochemical and MS detection AA Amir G Kazemifard, Douglas E Moore Journal of pharmaceutical and biomedical analysis 25 (5), 697-711, 2001 | 56 | 2001 |
| Extent of renal effect of cyclo‐oxygenase‐2‐selective inhibitors is pharmacokinetic dependent S Harirforoosh, A Aghazadeh‐Habashi, F Jamali Clinical and experimental pharmacology and physiology 33 (10), 917-924, 2006 | 53 | 2006 |
| Evaluation of glucosamine levels in commercial equine oral supplements for joints S Oke, A Aghazadeh‐Habashi, JS Weese, F Jamali Equine veterinary journal 38 (1), 93-95, 2006 | 53 | 2006 |
| Absorption and bioavailability of glucosamine in the rat A Ibrahim, MH Gilzad-Kohan, A Aghazadeh-Habashi, F Jamali Journal of pharmaceutical sciences 101 (7), 2574-2583, 2012 | 50 | 2012 |
| Drug-disease interaction: effect of inflammation and nonsteroidal anti-inflammatory drugs on cytochrome P450 metabolites of arachidonic acid A Aghazadeh-Habashi, W Asghar, F Jamali Journal of pharmaceutical sciences 107 (2), 756-763, 2018 | 34 | 2018 |
| Pharmacokinetics of meloxicam administered as regular and fast dissolving formulations to the rat: influence of gastrointestinal dysfunction on the relative bioavailability of … A Aghazadeh-Habashi, F Jamali European journal of pharmaceutics and biopharmaceutics 70 (3), 889-894, 2008 | 32 | 2008 |
| Rapidly dissolving formulations for quick absorption during pain episodes: ibuprofen. F Jamali, A Aghazadeh-Habashi International journal of clinical pharmacology and therapeutics 46 (2), 55-63, 2008 | 32 | 2008 |
| Cardiovascular effect of inflammation and nonsteroidal anti-inflammatory drugs on renin–angiotensin system in experimental arthritis W Asghar, A Aghazadeh-Habashi, F Jamali Inflammopharmacology 25, 543-553, 2017 | 31 | 2017 |
| Glucosamine dose/concentration-effect correlation in the rat with adjuvant arthritis A Aghazadeh-Habashi, MHG Kohan, W Asghar, F Jamali Journal of pharmaceutical sciences 103 (2), 760-767, 2014 | 31 | 2014 |
| Disease specific modeling: Simulation of the pharmacokinetics of meloxicam and ibuprofen in disease state vs. healthy conditions M Almukainzi, F Jamali, A Aghazadeh-Habashi, R Löbenberg European Journal of Pharmaceutics and Biopharmaceutics 100, 77-84, 2016 | 29 | 2016 |
| Simultaneous determination of selected eicosanoids by reversed-phase HPLC method using fluorescence detection and application to rat and human plasma, and rat heart and kidney … A Aghazadeh-Habashi, W Asghar, F Jamali Journal of pharmaceutical and biomedical analysis 110, 12-19, 2015 | 18 | 2015 |
| High performance liquid chromatographic determination of N-butyryl glucosamine in rat plasma A Aghazadeh-Habashi, J Carran, T Anastassiades, F Jamali Journal of Chromatography B 819 (1), 91-96, 2005 | 14 | 2005 |
| Tissue engineering through 3D bioprinting to recreate and study bone disease A Pavek, C Nartker, M Saleh, M Kirkham, S Khajeh Pour, ... Biomedicines 9 (5), 551, 2021 | 13 | 2021 |
| Bone-targeting parathyroid hormone conjugates outperform unmodified PTH in the anabolic treatment of osteoporosis in rats Y Yang, A Aghazadeh-Habashi, A Panahifar, Y Wu, KH Bhandari, ... Drug Delivery and Translational Research 7, 482-496, 2017 | 13 | 2017 |
| Single dose pharmacokinetics and bioavailability of butyryl glucosamine in the rat A Aghazadeh-Habashi, A Ibrahim, J Carran, T Anastassiades, F Jamali J Pharm Pharm Sci 9, 359-364, 2006 | 13 | 2006 |
